Teva swings to net, led by Copaxone, new launches By: MarketWatch February 16, 2010 at 06:41 AM EST Teva Pharmaceutical Industries Ltd. swings to a profit in the fourth quarter led by strength in its flagship multiple-sclerosis medication. Read More >> Related Stocks: Astrazeneca Plc ADR Novartis Ag ADR Sanofi-Aventis S.A. ADR